Final report of University Hospital Hradec Kralove to the clinical trial protocol no. P04736

Abstract

Realization of a part of clinical trial called A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of SCH 530348 in Addition to Standard of Care in Subjects With Acute Coronary Syndrome: Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRA•CER)

Keywords

• SCH 530348
• Acute Coronary Syndrome